CRDF
Cardiff Oncology Inc
1.20$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.7% | -9.3% | -10.8% | -4.8% | +54.5% | -12.7% | -10.7% | -15.8% | -3.0% | -20.5% | -24.1% | |
| – | -7.7% | -9.6% | -11.1% | -4.7% | +60.2% | -13.0% | -10.9% | -16.1% | -2.7% | -21.3% | -24.8% | |
| – | +42.2% | -13.8% | +36.7% | -48.9% | +294.8% | -53.2% | -55.2% | -6.0% | +72.4% | -51.1% | +7.6% | |
| – | -8.0% | -10.2% | -10.2% | -4.4% | +59.1% | -12.9% | -11.2% | -14.6% | -3.8% | -21.0% | -25.0% | |
| – | +45.5% | +36.5% | +14.8% | +37.0% | +25.1% | -47.6% | +29.9% | -51.7% | -28.3% | +4.9% | -1.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.0% | +10.5% | +3.9% | -1.2% | +5.5% | -2.2% | +23.0% | -12.5% | +10.0% | -12.3% | -25.3% | |
| – | +15.8% | +13.4% | +5.7% | +0.0% | +7.2% | -1.0% | +25.4% | -11.8% | +11.5% | -11.8% | -25.3% | |
| – | +0.4% | +0.7% | +0.9% | +0.7% | +0.4% | +0.8% | +0.7% | +0.7% | +0.6% | -11.5% | -29.3% | |
| – | -9.8% | +164.0% | -1.6% | -9.1% | +3.8% | -24.7% | +65.6% | -59.4% | +231.3% | -32.2% | -27.3% | |
| – | -10.4% | -12.7% | -14.0% | -5.7% | +67.9% | -14.6% | -17.3% | -16.7% | -7.0% | -23.5% | -23.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.3% | +4.6% | +1.7% | +0.0% | +39.6% | +0.5% | -0.1% | +2.3% | +0.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.